Universitätsklinikum Würzburg

Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma (2019) Zaremba A, Weishaupt C, Glutsch V, Schilling B, Loquai C, Rafei-Shamsabadi D, Meiss F, et al. Conference contribution Multicentric Sentinel Healthcare Research Project of Skin Cancer Centers in Nuremberg, Erlangen, Regensburg and Wuerzburg (2019) Enzelsberger K, Debus D, Schultz E, Haferkamp S, Hegemann MV, Stolze I, Erdmann M, Schellerer V Conference contribution Geriatric intensive care Consensus paper of DGIIN, DIVI, DGAI, DGGG, oGGG, oGIAIN, DGP, DGEM, DGD, DGNI, DGIM, DGKliPha and DGG (2019) Michels G, Sieber C, Marx G, Roller-Wirnsberger R, Joannidis M, Mueller-Werdan U, Muellges W, et al. Journal article The German National Registry of Primary Immunodeficiencies (2012-2017) (2019) El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, et al. Journal article Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell killing capability (2019) Ribechini E, Eckert I, Beilhack A, Du Plessis N, Walzl G, Schleicher U, Ritter U, Lutz MB Journal article The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells (2019) Mestermann K, Giavridis T, Weber J, Rydzek J, Frenz S, Nerreter T, Mades A, et al. Journal article Exploration of artificial intelligence use with ARIES in multiple myeloma research (2019) Loda S, Krebs J, Danhof S, Schreder M, Solimando AG, Strifler S, Rasche L, et al. Journal article Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension (2019) Bringhen S, Milan A, D'Agostino M, Ferri C, Waesch R, Gay F, Larocca A, et al. Journal article